Your browser doesn't support javascript.
loading
Long-term clinical outcomes of COVID-19 patients treated with imatinib.
Duijvelaar, Erik; Schippers, Job R; Smeele, Patrick J; de Raaf, Michiel Alexander; Vanhove, Arthur L E M; Blok, Siebe G; Twisk, Jos W R; Vonk Noordegraaf, Anton; de Man, Frances S; Bogaard, Harm Jan; Aman, Jurjan.
Afiliación
  • Duijvelaar E; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Schippers JR; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Smeele PJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • de Raaf MA; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Vanhove ALEM; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Blok SG; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Twisk JWR; Department of Epidemiology and Data Science, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Vonk Noordegraaf A; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • de Man FS; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Bogaard HJ; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands.
  • Aman J; Department of Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands. Electronic address: j.aman@amsterdamumc.nl.
Lancet Respir Med ; 10(4): e34-e35, 2022 04.
Article en En | MEDLINE | ID: mdl-35183270
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Respir Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Lancet Respir Med Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos